Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate)

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 6, 2001, Pages 1115-1119

  Romero Steiner, S ^a   Fernandez, J ^a   Biltoft, C ^a   Wohl, M E ^a   Sanchez, J ^a   Feris, J ^a   Balter, S ^a   Levine, O S ^a   Carlone, G M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; POLYRIBOSYLRIBITOL PHOSPHATE TETANUS TOXOID CONJUGATE; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIBODY PRODUCTION; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CONJUGATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

ANTIBODIES, BACTERIAL; COHORT STUDIES; DEVELOPING COUNTRIES; DIPHTHERIA TOXOID; DOMINICAN REPUBLIC; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HEALTH CARE COSTS; HUMANS; IMMUNOGLOBULIN G; INFANT;

EID: 0034761646     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.6.1115-1119.2001     Document Type: Article

References (24)

1. Variability in the functional activity of vaccines induced antibody to Haemophilus influenzae type b
2. Haemophilus influenzae type B, Neisseria meningitidis. Streptococcus pneumoniae, and Corynebacteriurn diphtheriae vaccines
3. Progress toward elimination of Haemophilus influenzae type B disease among infants and children - United States, 1987-1995
4. Randomized trial of the immunogenicity of fractional-dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine
5. Influenzal meningitis: Relation of age incidence to the bactericidal power of blood against the causal organism
6. Antibody avidity as a surrogate marker of successful priming to Haemophilus influenzae type b conjugate vaccines following infant immunization
7. The epidemiology of Haemophilus influenzae type b carriage among infants and young children in Santo Domingo, Dominican Republic
8. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
9. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines
10. Large-scale, post licensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: Practicality and effectiveness in preventing invasive of Haemophilus influenzae type b infections
11. Economizing vaccination against Haemophilus influenzae type b: A randomized trial of the immunogenicity of fractional- and two-dose regimens
12. Haemophilus influenzae type B infection
13. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b
14. Interlaboratory study evaluating quatitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay
15. Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccines in 7.5 micrograms liquid formulation: A comparison of three lots with the 15.0 micrograms lyophilized formulation
16. Randomized trial of Huemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants
17. Evaluation of vaccines for the prevention of pneumonia in children in developing countries
18. Spectrum and burden of severe Haemophilus influenzae type b diseases in Asia
19. Determination of parallelism and nonparallelism in bioassay dilution curves
20. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity
21. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin
22. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines
23. Induction of serum Haemophilus influenzae type b capsular antibodies in adult volunteers fed cross-reacting Escherichia coli O75:K100:H5
24. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae and Neisseria meningitidis